Clinical Endocrinology NewsWeight loss with semaglutide maintained for up to 3 yearsOctober 4, 2023DiabetesObesity
Clinical Endocrinology NewsFDA gives semaglutide two drug safety–related label changesSeptember 28, 2023DiabetesObesity
Clinical Endocrinology NewsThe ‘triple-G’ agonist for obesity management: Five things to knowSeptember 25, 2023Obesity
Clinical Endocrinology NewsTirzepatide superior to semaglutide for A1c control, weight lossSeptember 25, 2023DiabetesObesity
Clinical Endocrinology NewsWaist-hip ratio a stronger mortality predictor than BMISeptember 21, 2023Obesity
Clinical Endocrinology News‘New dawn’ for aldosterone as drug target in hypertension?September 12, 2023HypertensionObesity
Clinical Endocrinology NewsObesity-related cardiovascular disease deaths surgingSeptember 6, 2023Obesity
Clinical Endocrinology NewsWeight loss linked to mortality risk in older womenAugust 31, 2023ObesityPituitary, Thyroid & Adrenal Disorders
Clinical Endocrinology NewsMore weight loss linked with more benefit in STEP-HFpEFAugust 29, 2023Obesity
Clinical Endocrinology News‘Patients fail’ despite benefits of sustained weight lossAugust 25, 2023Obesity
